Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells.
Key Features
- The global Medical Alpha Radionuclide market size is projected to grow from US$ 3467 million in 2024 to US$ 8080 million in 2030, expected to grow at a CAGR of 15.1% from 2024 to 2030.
Segmentation by Type
- Actinium-225
- Astatine-211
- Lead-212
- Bismuth-213
- Others
Segmentation by Application
- Immunotherapy
- Peritoneal Carcinomas
- Bone Metastases
- Leukaemia
- Melanomas
- Solid Tumours
Market by Region
- Americas: United States, Canada, Mexico, Brazil
- APAC: China, Japan, Korea, Southeast Asia, India, Australia
- Europe: Germany, France, UK, Italy, Russia
- Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries
Company’s Coverage
- ORNL
- Tri-Lab
- SSC RF-IPPE
- JRC Karlsruhe
- TerraPower
- TRIUMF
- Eckert&Ziegler
- Ionetix
- Orano Med
- National Nuclear Laboratory
- NorthStar
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Medical Alpha Radionuclide market?
- What factors are driving Medical Alpha Radionuclide market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Medical Alpha Radionuclide market opportunities vary by end market size?
- How does Medical Alpha Radionuclide break out by Type, by Application?
Frequently Asked Questions
What is the USP of the report? expand_more
Medical Alpha Radionuclide report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Medical Alpha Radionuclide report is categorised based on following features:
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Medical Alpha Radionuclide report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.